Deciphera Pharmaceuticals, Inc. - Common Stock (NQ:DCPH)

25.59 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 10, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Deciphera Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024

February 01, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

February 01, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium

January 18, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

What 4 Analyst Ratings Have To Say About Deciphera Pharmaceuticals ↗

November 20, 2023

Via Benzinga

Earnings Preview: Deciphera Pharmaceuticals ↗

August 08, 2023

Via Benzinga

The Latest Analyst Ratings for Deciphera Pharmaceuticals ↗

May 04, 2023

Via Benzinga

Recap: Deciphera Pharmaceuticals Q1 Earnings ↗

May 03, 2023

Via Benzinga

Deciphera Pharmaceuticals Announces Planned 2024 Corporate Milestones Supporting Evolution to a Self-Sustaining, Multi-Product Company

January 08, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIST Patients with Mutations in KIT Exon 11 and 17/18

January 05, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

November 29, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences

November 07, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals' Investigational Drug Shows Encouraging Response Rates In Rare Type Of Cancer ↗

October 30, 2023

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) announced top-line results from the MOTION Phase 3 study of vimseltinib in patients with Tenosynovial Giant Cell Tumor (TGCT)

Via Benzinga

Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday ↗

October 30, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Deciphera Pharmaceuticals Announces Third Quarter 2023 Financial Results

October 30, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals Announces Positive Top-line Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) and Updated Results from Phase 1/2 Study of Vimseltinib in TGCT

October 30, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 15, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Want to Get Rich? 3 Game-Changing Biotech Stocks to Buy Right Now ↗

August 21, 2023

Biotech stocks may offer some of the most explosive opportunities on the market. Here are three with major catalysts nearing.

Via InvestorPlace

3 Under-the-Radar Biotech Stocks to Buy in 2023 ↗

August 19, 2023

All three biotech companies focus on oncology therapies.

Via The Motley Fool

Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 18, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Why Shares of Deciphera Pharmaceuticals Rose This Week ↗

August 11, 2023

The company's shares rose after the company reported second-quarter earnings.

Via The Motley Fool

Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analyst ↗

August 10, 2023

Stifel upgraded Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) to Buy from Hold, with a price target of $20 from $14, after reevaluating the competitive landscape for the 2L GIST market.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023 ↗

August 10, 2023

Via Benzinga

Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday ↗

August 10, 2023

Keybanc cut the price target for i3 Verticals, Inc. (NASDAQ: IIIV) from $28 to $26. Keybanc analyst Josh Beck maintained an Overweight rating. i3 Verticals shares fell 2.9% to close at $22.76 on...

Via Benzinga

Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results

August 09, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals Announces Retirement of Daniel L. Flynn, Ph.D., and Appointment of Dashyant Dhanak, Ph.D., as Executive Vice President and Chief Scientific Officer

August 03, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast on August 9, 2023

August 02, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Present Data from INTRIGUE Phase 3 Study of QINLOCK® (ripretinib) and Trial-in-Progress Poster for INSIGHT Pivotal Phase 3 Study of QINLOCK® at the 2023 American Society of Clinical Oncology Annual Meeting

May 25, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences

May 23, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

May 08, 2023

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.